Proteome Sciences Share Discussion Threads

[pools2] 17/7/2023 12:00

That's why PRM's share price is going up vertically when we finally get some "coverage".

[monte1] 17/7/2023 11:51

No.

vbrs

[dominiccummings] 16/7/2023 21:58

Gone awfully quiet here. Is anyone there?

[049balt] 10/7/2023 16:19

Very interesting Collinhy. So stroke now at an advanced stage.

[colinhy] 10/7/2023 10:41

Randox marketing presentation on June 2 2023 of their Analyser Biochip Arrays for clinical diagnostics, see below slide for Stroke Test and accompanying dialogue by Randox Sales Manager.




"So lastly we wanted to touch on an exciting upcoming panel the Roundup stroke array will be a rapid and highly sensitive blood test to complement and enhance existing CT scanning technology for-stroke diagnosis this panel will be available on the multi-stat or point of care instrument making it very suitable for emergency settings.
The biomarkers that have been selected and designed they are designed to differentiate and classify patients with either ischemic or hemorrhotic stroke so this is a really exciting array that is coming up that will be available for the multi-step the stroke array it's really relevant for those Emergency Settings because it provides results in as little as 30 minutes."

[colinhy] 10/7/2023 10:36

Randox marketing presentation on June 2 2023 of their Analyser Biochip Arrays for clinical diagnostics, see below slide for Stroke Test and accompanying dialogue by Randox Sales Manager.




"So lastly we wanted to touch on an exciting upcoming panel the Roundup stroke array will be a rapid and highly sensitive blood test to complement and enhance existing CT scanning technology for-stroke diagnosis this panel will be available on the multi-stat or point of care instrument making it very suitable for emergency settings.
The biomarkers that have been selected and designed they are designed to differentiate and classify patients with either ischemic or hemorrhotic stroke so this is a really exciting array that is coming up that will be available for the multi-step the stroke array it's really relevant for those Emergency Settings because it provides results in as little as 30 minutes."

[pools2] 07/7/2023 16:08

Page 14 and 15

Stroke Array

RAPID IDENTIFICATION AND STRATIFICATION OF ACUTE STROKE SUBTYPES
Benefits
Unique Solution for Stroke Classification
Unique solution for simultaneous detection of multiple stroke-associated biomarkers from a single sample, facilitating rapid and accurate stroke subtype classification.
Enhances Existing Scanning Technologies
Complements and enhances existing CT scanning approaches which enables a more comprehensive evaluation of a suspected stroke patient upon admission.
Improves Patient Care
Ensuring appropriate timely therapeutic intervention. Rapid thrombolytic therapy ensures a better outcome.
Results in 39 Minutes
Fully automated analyser that is easy to use and provides a fast turnaround time.
Accessible Stroke Management
Unlike larger CT/MRI scanning technologies, the MultiSTAT is a benchtop analyser with a small footprint.

[pools2] 07/7/2023 10:02

As wasjobber mentioned, it does seem the MM's are trying to force this down on next to no volume. I guess he's correct suggesting MM's are short of stock at a lower range. It's amazing how the share price can be manipulated.

[peverill] 06/7/2023 21:38

Like it was at a £.They don't have anything other than TMT and that is hardly setting the pharma world alight,despite being on the market 15 years.

[pools2] 06/7/2023 10:38

Our wonderful ADVFN website currently calculates a PE of 1968.75 for PRM.

In fact it's two orders of magnitude out. The ACTUAL PE is only 19.6875.

PRM is an absolute steal at these levels !!!

[dominiccummings] 05/7/2023 21:49

That's 'luckily' Small crow?

[small crow] 05/7/2023 18:38

"...they're short of stock." Luckily, I'm not.

[pools2] 05/7/2023 17:54

New Procedures Enhance Quality Control for Large-Scale Plasma Proteomics Analyses

[goggin] 05/7/2023 15:38

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023Source: Business WireThermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2023 before the market opens on Wednesday, July 26, 2023, and will hold a conference call on the same day at 8:30 a.m. EDT.

[dominiccummings] 05/7/2023 13:21

Hang on. The MMs want your shares.

[teh hampster] 05/7/2023 10:31

Treeshake?

[coldale1] 05/7/2023 08:24

The only way I would add here is on big news. Anything else is a gamble as you well know 049Balt...

[049balt] 04/7/2023 20:58

We have held most of recent gains. There is no pump and dump, just an investor who believes, like me, that this company is way undervalued. There are very shares available and any significant buying will inevitably drive up the price.The rise has been accompanied by the usual vitriol here, which is a good sign ironically, as we climb against a wall of non believers it gives me some comfort . If we can get above 10p and hold that then I will add to my holdings.